- Who can participate: Adults aged 18 to 65 with a diagnosis of the specified health condition and no history of severe allergic reactions are eligible to participate.
- Study details: Participants will undergo initial screening, followed by regular visits where they will receive the assigned treatment and undergo health assessments. The study includes a placebo group for comparison.